Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LW0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,437
Award facts
- Contract value 100% obligated
- $28,436.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,436.88 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial, with a completion date of February 10, 2026. This firm fixed-price delivery order was awarded on January 20, 2026, without a set-aside designation, indicating competitive selection through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Department of Defense and Veterans Affairs. The company's extensive contract portfolio with DLA demonstrates its capability to supply specialty medications, brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for immunoglobulin therapy reflects the company's role in supplying essential biological products required by military treatment facilities and defense healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9LW0?
SPE2DR26F9LW0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LW0 worth?
The government has obligated $28,437 on SPE2DR26F9LW0.
Is contract SPE2DR26F9LW0 an order under another contract?
Yes. SPE2DR26F9LW0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LW0 competed?
The extent of competition for SPE2DR26F9LW0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award